Gemtide Injection (2.4ml Each)
Marketer
Alkem Laboratories Ltd
Salt Composition
Teriparatide (600mcg)
Overview Gemtide Injection (2.4ml Each)
Parathyroid hormone analog, Gemtide Injection (2.4ml vials), treats severe osteoporosis and fracture risk in men and postmenopausal women. Its mechanism involves stimulating bone growth, thereby increasing bone density and reducing spinal fracture likelihood. Administered subcutaneously or by a healthcare provider, Gemtide requires consistent daily self-injection for optimal efficacy. Treatment typically lasts up to two years, though adherence to the physician's prescribed course is crucial, regardless of symptom improvement. Refrigerate at 2-8°C. Common adverse effects include arthralgia, injection site inflammation (pain, edema, erythema), and lower extremity cramps; persistent or bothersome symptoms warrant medical attention. Prior to Gemtide initiation, disclose any kidney conditions (including nephrolithiasis) to your doctor due to potential hypercalcemia. Pregnant or lactating individuals require physician consultation before commencing treatment. Regular bone density monitoring via scans may be recommended.
Uses of Gemtide Injection (2.4ml Each)
Bone fragility
Major Benefits of Gemtide Injection (2.4ml Each):
Administering this medication requires a healthcare professional; patient self-medication is strictly prohibited.
Common Side effects of Gemtide Injection (2.4ml Each):
- Joint pain
- Injection site reactions (pain, swelling, redness)
- Nausea
- Leg cramps
How to use Gemtide Injection (2.4ml Each):
The medication will be administered by your physician or their assistant; self-medication is strictly prohibited.
How Gemtide Injection (2.4ml Each) works:
Each 2.4ml vial of Gemtide Injection delivers a synthetic analog of the naturally occurring parathyroid hormone (PTH). Its mechanism involves stimulating osteoblast proliferation and activity, leading to enhanced bone strength and a reduced fracture risk.
SAFETY ADVICE
AlcoholCAUTION
Exercise caution when using Gemtide Injection (2.4ml vials) concurrently with alcohol. Physician consultation is recommended.
PregnancyCONSULT YOUR DOCTOR
The use of Gemtide Injection (2.4ml vials) during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the advantages against possible risks prior to prescribing. Physician consultation is advised.
Breast feedingCONSULT YOUR DOCTOR
Data on the compatibility of Gemtide Injection (2.4ml vials) with breastfeeding are currently unavailable. Seek medical advice from your physician.
DrivingUNSAFE
Administration of Gemtide Injection (2.4ml per dose) can induce drowsiness, visual disturbances, and dizziness. Driving is inadvisable if these effects are experienced.
KidneyCAUTION
Administering Gemtide Injection (2.4ml vials) requires caution in individuals with impaired renal function. Dosage modification of Gemtide Injection (2.4ml vials) might be necessary. Physician consultation is advised. Gemtide Injection (2.4ml vials) is contraindicated for patients exhibiting severe kidney disease.
LiverCONSULT YOUR DOCTOR
Insufficient data exists regarding the use of Gemtide Injection (2.4ml vials) in individuals with hepatic impairment. Physician consultation is advised.
What if you forget to take Gemtide Injection (2.4ml Each) :
Should you forget a Gemtide Injection (2.4ml vial), administer it at your earliest convenience. If, however, your next scheduled dose is imminent, omit the missed injection and resume your usual dosing regimen. Never take a double dose.
Facts to Know About Gemtide Injection (2.4ml Each)
| Label | Value |
|---|---|
| Type of Compound | Synthetic Parathyroid Hormone Preparations |
| Addictive | None. |
| Medication Classification | Endocrine Regulators |
3,018 People bought this recently